Virginia Tech biomedical spinoff cited for innovation by national university associations
November 13, 2017
A Virginia Tech spinoff company formed to fight a deadly type of brain cancer is being recognized this week by the Association of Public and Land-Grant Universities (APLU) and the Association of American Universities.
Samy Lamouille, a research assistant professor at the Virginia Tech Carilion Research Institute and chief executive officer of Acomhal Research Inc. in Roanoke, Virginia, will represent the company at the APLU’s University Innovation and Entrepreneurship Showcase at the Rayburn House Office Building in Washington, D.C., on Tuesday.
Acomhal Research, which was founded by Lamouille and Rob Gourdie, the Commonwealth Research Commercialization Fund Eminent Scholar in Heart and Regenerative Medicine at VTCRI, is one of 22 companies selected nationally to highlight how federally funded university research improves lives and fuels entrepreneurship and innovation.